Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT02678260
Eligibility Criteria:
Inclusion Criteria:
* Patients with advanced/metastatic solid tumors, with measurable or non-measurable disease as determined by response evaluation criteria in solid tumors (RECIST) version 1.1, who have progressed despite standard therapy or are intolerant of standard therapy, or for whom no standard therapy exists
* ECOG Performance Status ≤ 2
Exclusion Criteria:
* Active autoimmune disease
* Active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
* Prior PD-1- or PD-L1-directed therapy
Other protocol defined inclusion/exclusion may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02678260
Study Brief:
Protocol Section:
NCT02678260